Monitoring device for heart and liver transplant surgery
This study is testing a new monitoring device during heart or liver transplant surgery. It aims to see if the device helps doctors better manage your blood flow and oxygen levels during the operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- A pulmonary artery catheter must be planned for your surgery.
- You must be scheduled for heart or liver transplant surgery that lasts more than 2 hours.
- If you are in the heart group, you must have a certain heart rhythm and no signs of heart failure or infection.
- If you are in the brain injury risk group, you must be 45 or older and have risk factors like high blood pressure, diabetes, or a history of stroke.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a device that monitors blood pressure continuously during surgery using a finger cuff, instead of the standard arm cuff that gives readings every few minutes. You may be able to join if you are having surgery and are at higher risk of complications during anesthesia.
This trial tests a new method to monitor blood pressure during heart surgery that uses a heart-lung machine. It is for people at higher risk for stroke or other brain blood vessel issues.
This study checks whether a new non-invasive measurement of oxygen delivery is accurate in patients having heart surgery. Participating may help improve monitoring during and after surgery, without extra procedures beyond what is already part of your care.
This study tests a device called UltraTrac that checks your heart and lung health without needles or invasive procedures. It may help doctors better monitor conditions like heart failure or asthma in the future.
This study tests a new non-invasive device called UltraTrac that measures how well the heart pumps blood in people with congenital heart disease. It will be used during standard heart procedures or intensive care stays to see if it works as well as current methods.
This study looks at a new way to monitor blood flow in tiny blood vessels during liver transplant surgery. It may help doctors better understand how well blood is reaching tissues during the operation.
Hear when a new Hemodynamic Instability trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.